C

Cullinan Oncology
D

CGEM

16.465
USD
0.49
(3.04%)
مغلق
حجم التداول
27,860
الربح لكل سهم
0
العائد الربحي
0
P/E
-5
حجم السوق
954,585,394
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Cullinan Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancerand autoimmune indications.